Mangoceuticals, Inc.
MGRX
$1.11
$0.043.74%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -49.91% | 53.80% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -49.91% | 53.80% | |||
| Cost of Revenue | -57.42% | 65.68% | |||
| Gross Profit | -43.38% | 44.77% | |||
| SG&A Expenses | 43.94% | 50.23% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 42.46% | 50.43% | |||
| Operating Income | -45.46% | -50.33% | |||
| Income Before Tax | -40.68% | -11.91% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -40.68% | -11.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -100.00% | |||
| Net Income | -40.67% | -11.91% | |||
| EBIT | -45.46% | -50.33% | |||
| EBITDA | -73.01% | -43.29% | |||
| EPS Basic | -26.56% | 48.51% | |||
| Normalized Basic EPS | -24.73% | 49.70% | |||
| EPS Diluted | -26.56% | 48.51% | |||
| Normalized Diluted EPS | -24.73% | 49.70% | |||
| Average Basic Shares Outstanding | 15.43% | 117.36% | |||
| Average Diluted Shares Outstanding | 15.43% | 117.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||